The Chung Lab at USC has developed a nanoparticle that attaches to immune cells, allowing it to target lymph nodes—a vital indicator of cancer metastasis—and enhance MRI detection, potentially ...
DUBLIN, Ohio--(BUSINESS WIRE)--Navidea Biopharmaceuticals, Inc. (NYSE MKT:NAVB) has announced that the European Commission has granted marketing authorization for Lymphoseek® 250 micrograms kit for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results